Document Type : Original Article
Authors
1 General surgery department, Shebin Elkom teaching hospital, Shebin Elkom, Menoufia, Egypt
2 General Surgery Department, Menoufia University, Shebin Elkom, Menoufia, Egypt
Abstract
Keywords
INTRODUCTION
Not only does the breast cancer brings the woman face to face with her mortality, but also its surgical treatment is accompanied by physical changes to the breast and body that may significantly, and often permanently, alter her perception of her physical, emotional, and sexual wholeness.1
The replacement of obligatory mastectomy by simple mastectomy or wide local excision and adjuvant radiotherapy, reflected a shift in the understanding of breast cancer pathology and biology.2 A balance between good cosmetic outcome and limiting the risk of recurrence remains the key to success.3
Centrally located tumors have long been thought to be associated with a higher incidence of multi-centricity and multi-focality but more recent reports have failed to substantiate this specific correlation.4
For centrally-located breast cancer (CLBC), the nipple-areolar-complex (NAC) preservation surgery had not been generally recommended because of their highly malignant involvement but later on NAC preserving surgery was found to be clinically and oncologically sound treatment in NAC-free patients.5
The aim of our study is to evaluate the feasibility of the breast conservative surgery in patients with retro-areolar breast cancer..
PATIENT AND MATERIALS
Eighteen patients with Stage I or IIa retro-areolar breast cancer were included in our study at Department of General surgery, Menoufia University in the period from January 2014 to December 2015. Patients with advanced tumor, peripherally located tumors or tumor < 1 cm from the NAC were excluded from the study. Ethical clearance was taken before the start of the study from the ethical committee.
All patients were assessed preoperatively by full history taking including age of the patient, history of medical importance as smoking, past history of systemic diseases as diabetes, hypertension … etc., history of previous breast diseases as breast masses, pain and nipple discharge, history of previous breast surgery, family history of breast cancer especially in first degree relative.
Also, assessment of the retro-areolar breast lump was done through examining its texture, mobility, fixation to the skin, underlying muscles, or chest wall and involvement of the NAC. Axillary lymph nodes were palpated for number and mobility. All patients in the study underwent complete blood count (CBC), coagulation profile, liver function tests, renal function tests and blood glucose level. Patients were also assessed radiologically by mammography, breast ultrasonography, chest x-ray, abdominal ultrasonography and electrocardiography. The diagnosis of carcinoma of the breast was assured by preoperative needle biopsy or Tru-cut. All patients had counsel and consent for the procedure, risk, possible complications, re-do surgery or the need for immediate or delayed modified radical mastectomy.
In patients with tumor less than 1 cm, immediate preoperative localization by sonar-guided wire insertion was done to obtain adequate symmetrical resection margins.
All patients were subjected to lumpectomy with NAC preservation. Treatment of axilla was done according to the stage of breast cancer.
During the procedure, the lesion was marked while the patient was awake to facilitate location of the tumor in the operating room. The patient was placed in the supine position with the arm abducted to 90 degrees. A circum-areolar incision was performed. The skin was then grasped with tissue forceps and electrocautery was used to dissect subareolarly to create a nipple-areolar complex flap. The dissection continued to remove the mass. The wound was then closed using inverted 3-0 absorbable Vicryl sutures and sub-cuticular 4-0 or 5-0 sutures. Axillary lymph node management was done through a separate axillary incision. Suction drains were placed. Axillary lymph node management was done through a separate axillary incision.
All patients were discharged from the ward 24 h after operation with suction drain and with proper antibiotics. Follow up of suction drain for hemorrhage or seromas. Aesthetic and oncological outcome and patient satisfaction for distortion, mal-position, asymmetry, contour, deformity and scar were evaluated.
The assessment was classified to short term observation after one week and long term follow-up every 3 months where the aesthetic and oncological outcome and patient satisfaction for distortion, mal-position, asymmetry, contour, deformity and scar were evaluated. Follow up was done by clinical examination, mammography and breast ultrasonography and metastatic evaluation by chest x-ray and abdominal ultrasound.
Data was collected and entered to the computer using SPSS (Statistical Package for Social Science) program version 13.0, SPSS Inc., Chicago, Illinois, USA for statistical analysis. Data entered as numerical or categorical, as appropriate. Quantitative data was shown as mean, SD, and range. Qualitative data was expressed as frequency and percentage. Statistical analysis was done using Chi-square (Goodness-of-fit) test for qualitative data and one sample t-test for quantitative data. P (probability) value will be considered to be of statistical significance if it is less than 0.01.
RESULTS
Our study included eighteen patients; all of them were treated by lumpectomy with NAC preservation (Figure 1).
Fig. 1: A case of lumpectomy of a mass 1 cm deep to the NAC with NAC preservation.
(a) Shows the lump. (b) Shows the wound after removal of the lump. (c) Shows the retroareolar tissue after removal of the lump. (d) Shows the wound prior to closure. (e) Shows the wound after closure with axillary dissection and insertion of drains.
The age ranged from 31-59 years with a mean of 44.5 ± 8.12 years. Demographically, 12 patients (66.67%) were pre-menopausal while only 6 patients were post-menopausal, 11 patients (61.11%) were found to have positive past history of breast disease; 4 patients (22.22%) had fibroadenosis and the remaining 7 patients (38.89%) had biopsies in the form of fine needle aspiration, 4 patients (22.22%) were found to have positive family history of breast cancer (Figure 2).
Fig. 2: Bar graph showing the demographic data among the patients.
During the preoperative assessment, 11 patients (61%) were found to have right retro-areolar breast mass while the remaining 7 patients (39%) had left breast mass, 4 patients (22.22%) were found to have a mass smaller than 1 cm, twelve patients (66.67%) with tumors ranging in size from 1 to 2 cm and two patients (11.11%) with tumors larger than 2 cm with a mean of 1.7 ± 0.78 cm with statistical significance (Table 1).
Preoperative findings |
Number of patients |
p value |
|
Side of the affected breast |
Right |
11 (61.11%) |
0.346 |
Left |
7 (38.89%) |
||
Preoperative mass size |
< 1 cm |
4 (22.22%) |
0.009 |
1-2 cm |
12 (66.67%) |
||
> 2 cm |
2 (11.11%) |
Table 1: Preoperative findings among the patients
Regarding nipple-tumor distance (N-T distance), the minimum distance was 1 cm while the maximum distance was 3 cm with a mean of 1.933 ± 0.556 cm (Figure 3).
Fig. 3: Line graph showing the nipple-tumor distance.
By postoperative histopathology, the mean size of the excised mass was 2 ± 0.88 cm.9 patients (50%) had tumors < 2 cm (T1 stage) while the remaining belong to T2 stage with tumor size ranging from 2-4 cm. The resection margins of the excised mass were 1.283 ± 0.583 cm and were found to be clear of malignant cells. Axillary lymph nodes were positive for malignancy in 6 patients (33.33%) in whom axillary clearance was done.
13 patients (72.22%) were found to have invasive ductal carcinoma, 3 patients (16.67%) with invasive lobular carcinoma and 2 patients (11.11%) with invasive mixed carcinoma with statistical significance. 5 patients (27.78%) were stage I breast cancer with T1 N0 M0 stage while the remaining (72.22%) were stage II breast cancer with T1 N1 M0 (4 patients) or T2 N0 M0 stages (9 patients) (Table 2).
Histological findings |
Number of patients |
p value |
|
Axillary Lymph node |
Positive |
6 (33.33%) |
0.157 |
Negative |
12 (66.67%) |
||
Histological type |
Invasive ductal carcinoma |
13 (73.22%) |
0.002 |
Invasive lobular carcinoma |
3 (16.67%) |
||
Invasive mixed carcinoma |
2 (11.11%) |
||
TNM classification |
T1 N0 M0 |
5 (27.78%) |
0.311 |
T1 N1 M0 |
4 (22.22%) |
||
T2 N0 M0 |
9 (50%) |
Table 2: The histological findings among the patients
Three patients (16.67%) had wound infection, 2 patients (11.11%) had seroma in the subcutaneous tissue and only 1 patient (5.5%) had partial slough of the NAC. All these patients responded to medical treatment. The other 12 patients (66.66%) had no complications. The difference was statistically significant (Table 3).
Postoperative Complications |
Number of patients |
p value |
Wound infection |
3 (16.67%) |
0.001 |
Seroma |
2 (11.11%) |
|
NAC complication |
1 (5.55%) |
|
Negative |
12 (66.67%) |
Table 3: Postoperative Complications among the patients
Regarding the oncological outcome, recurrence occurred only in 2 patients. Recurrence occurred after 12 months in the first patient while it occurred after 18 months in the second patient. This was significant statistically (Table 4).
Oncological Outcome |
Number of patients |
Percentage |
p value |
|
Recurrence |
-ve |
16 |
88.89% |
0.001 |
+ve |
2 |
11.11% |
Table 4: Oncological Outcome among the patients
The cosmetic outcome was assessed by using the questionnaire made by Tzafetta and colleagues in 2011 (Figure 4).6
Fig. 4: The questionnaire used for cosmetic assessment
The cosmetic outcome was excellent in 9 patients, good in 7 patients and fair in only 2 patients. 16 patients were satisfied by the end results. This was significant statistically (Table 5).
Variable |
Number of patients |
Percentage |
P-value |
|
Cosmetic outcome |
Excellent |
9 |
50% |
0.115 |
Good |
7 |
38.89% |
||
Fair |
2 |
11.11% |
||
Patient Satisfaction |
Yes |
16 |
88.89% |
0.001 |
No |
2 |
11.11% |
Table 5: Cosmetic Outcome among the patients
DISCUSSION
Patients with central tumors involving or close to the Nipple-Areola-Complex (NAC) account for 5 to 20% of breast cancer cases and, for a long time, they have routinely been denied the opportunity for breast conservation.7,8 They have long been accused of being associated with a high incidence of multi-centricity and multi-focality. Moreover, in the majority of these cases, sound oncologic surgery requires excision of the NAC with the central part of the breast which yields unacceptable cosmetic results.9
There are several predictive indicators of NAC involvement have been studied including tumor size, tumor distance from the nipple, node status and multi-centricity or multi-focality.
Cense and colleagues in 2001 reviewed the literatures dealing with NAC involvement, and concluded that the most important predictors were the nipple-tumor distance and the tumor size.10 Loewen and colleagues in 2008 concluded that the mammographic distance between the nipple and the tumor is independently predictive of NAC involvement.11 We used the nipple-tumor distance as a predictor for NAC involvement.
Rulli and colleagues in 2013 showed that a nipple-tumor distance less than 2.5 cm was considered as exclusion criteria from nipple-sparing while the distance used in Crowe and colleague study was > 1 cm.12,13 Crowe and others in 2004, who used the 1 cm as a cut-off for nipple sparing, had no recurrence among their 48 patients.13 They had only 3 patients with partial NAC slough. This made the Nipple-tumor distance of 1 cm as an appropriate distance for nipple preservation.
In our study, the distance between the mass and the NAC ranged 1-3 cm with a mean of 1.9 ± 0.56 cm.
The age of the patients ranged from 31 years to 59 years with a mean of 44.5 ± 8.12 years. This was lower than Rulli and colleagues study in 2013 where the mean of age was 50 years with the age of the patients ranged from 32 years to 74 years.12 About 75% of our patients had an age below 50 years. In Ren and colleagues study, 82% of patients were below 50 years.14 Most of the patients were premenopausal (66.67%) with positive past history of breast disease (61.11%), negative family history (77.78%) and predominately right breast mass in 11 patients (61.11%) with no impact on the operative procedure or the postoperative findings.
Data on the oncological reliability and feasibility of nipple preservation have been analyzed in many studies. Several authors have assessed the risk of sub-areolar recurrence after this surgical technique. It was found that sub-areolar recurrence risk increases with increasing tumor size.12
The mean size of tumors determined pathologically was 2 ± 0.883 cm with a range of 0.7-4 cm. While in Rulli and colleagues study, the mean size was 1.3 cm with a range of 0.2-2.5 cm.12
Central breast tumors represent a challenge to the surgeon who must fulfill the fundamental goals of BCS, namely adequate margins and acceptable appearance.7 In all patients, the resection margins after excision were negative for any residual neoplasm.
The mean of the resection margin was 1.283 ± 0.583 cm with a range of 0.2-2 cm. Ren and colleagues in 2014 made resection-free margins of > 1 cm in all patients. They stated that all patients with preservation of the NAC must obtain a negative surgical margin.14
Positive axillary lymph nodes were found in one third of the patients (6 Patients). All of them were movable and belonged to level I or II on the same side of the affected breast. Axillary lymph node clearance was completed in whenever positive one or both axillary lymph node levels were encountered (6 patients). In Ren study, it was positive in 27 out of 91 patients (17%).14 This discrepancy is due to small number of patients in our study.
The incidence of positive axillary nodes was 33.3% while it was 43.5% in other studies.7 These incidences are lower than the reported incidence with breast cancer of all stages at the National Cancer Institute that ranges from 62% to 96.5%. This is probably due to early case selection and less number of patients.
All the tumors in this study were found to be invasive with the predominance of the invasive ductal carcinoma (IDC) in 13 patients (72.22%) (p 0.002) while in the study of Ren and others, 61 patients (67%) were found to have (IDC) but they had 12 patients (13%) diagnosed with ductal carcinoma in-situ (DCIS) with no patient in our study had such diagnosis.14
One patient (5.56%) developed partial slough of the NAC. In Rulli and colleagues study, most patients reported lack of sensitivity of the nipple skin postoperatively12 while in Crowe and colleagues study, 3 patients reported partial slough of the NAC. Crowe claimed that superficial tissue loss of the NAC was common during the first 7 to 21 postoperative days but the 45 lumpectomy with nipple preservation performed through a lateral incision are completely intact and well healed, with good cosmesis.13
Half of the patients (9 patients) had Excellent cosmetic outcome and 7 patients (39%) had Good outcome. This is different from the results reported by Wagner and colleagues in 2007 who reported Excellent up to 80%, and Good up to 20%.15
Sixteen patients (88.87%) were satisfied with the results (p 0.001). Most patients were satisfied because they preserved their breasts despite of the presence of the cancer. Both patients, who were not satisfied, were found to have eventful postoperative course. Both had postoperative wound infection that required frequent dressings and antibiotics administration for about one month that resulted in fair cosmetic outcome.
Follow-up was done every 3 months. Follow-up was done by using the clinical examination and radiological investigations. Only 2 patients (11.11%) had recurrence after 12 and 18 months (p 0.001). Both patients had stage II breast cancer with T2 N0 M0 with negative sentinel lymph node. They received postoperative radiotherapy but they were found to have narrow resection margins of only 2 and 4 mm respectively. Both patients had modified radical mastectomy.
CONCLUSION
Breast conserving surgery is a suitable procedure for early retroareolar breast cancer. It is safe oncologically with no locoregional recurrence and good cosmetic outcome with good patient satisfaction.